Cystitis and its management by Soler, Gillian
Issue 22  2016 Journal of the Malta College of Pharmacy Practice          21
Introduction
Urinary tract infections (UTIs) are divided 
into lower and upper tract infections. Lower 
UTIs (LUTIs) include the bladder and urethra, 
whereas upper UTIs involve the kidneys. 
Many a time, the infection migrates from 
one part of the tract to another. Most UTIs 
are caused by bacteria, although sexually 
transmitted pathogens, mycobacteria, 
fungi and parasites also give rise to such 
infections.3 
Bacterial UTIs involve any part of the 
urinary tract and may be asymptomatic or 
characterized by the symptoms that are 
normally associated with these infections. 
Diagnosis focuses on the doctor taking a 
detailed history of the presenting complaints 
by the patient, together with a urine analysis 
and urine culture. Treatment usually involves 
the use of antibiotics. When considering 
adults up to 50 years of age, bacterial UTIs 
are much more common in females. The 
incidence of these infections increases in 
both male and female patients over 50 years 
of age. On the other hand, the female:male 
ratio decreases, a reason being an increased 
frequency of prostate disease.3
The urinary tract is normally a sterile 
environment and this is very often 
maintained due to various reasons which may 
include the acidity of the urine, emptying 
of the bladder at micturition and various 
immunological and mucosal barriers. Most 
UTIs occur when the pathogenic bacteria 
ascend the urethra to the bladder.3 A 
bacterial infection of the urethra, urethritis, 
is mainly caused by the sexually transmitted 
pathogens, Chlamydia trachomitis, and 
Neisseria gonorrhoea.1 
Cystitis is the term used to describe a 
bladder inflammation that is very often due 
to an infection which is usually of bacterial 
origin. Examples of such micro-organisms 
include Escherichia coli (70-95% of all 
cases) and Klebsiella pneumonia. A bladder 
infection may become a serious health 
problem if not treated, as the infection will 
otherwise spread to the kidneys. This may 
result in renal failure or pyelonephritis.3 Due 
to complications of cystitis, mortality rates 
can be as high as 1% in men and 3% in 
women.1 
Non-infective episodes of cystitis are rare 
and they may be due to:1
•	 radiation therapy
•	 certain medicines such as 
cyclophosphamide; this is thought to be 
due to the metabolites that are excreted 








Urinary tract infections are very common. They are responsible 
for over 6 million patient visits to doctors per year in the United 
States.1 These include over 2 million cases that are attributed to 
cystitis which is the most common urinary tract infection. Cystitis 
can be defined as an inflammation of the bladder and it may result 
in pain and discomfort. Women tend to suffer from this condition 
more than men, although the chance of men acquiring cystitis 
increases with age. Untreated cystitis can lead to kidney infection, 
even kidney damage. Treatment for cystitis ranges from over-the-
counter medications to antibiotics if the cause is an infection.2
Cystitis and its management
Educational aims
•	 To provide an overview of urinary tract infections and cystitis, underlying the difference 
between the latter and interstitial cystitis
•	 To outline the major causes of cystitis and the signs and symptoms that are associated 
with it
•	 To describe the different tests that are used to diagnose an episode of cystitis
•	 To highlight the various classes of medications that are used to prevent and treat cystitis
•	 To offer a series of recommendations for lifestyle modifications that will help prevent 
further episodes
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related to the dose of medication taken 
and to the duration of therapy 
•	 the long-term use of a catheter
•	 hypersensitivity to certain chemicals 
that can be found in spermicidal gels, 
feminine hygiene sprays and shower 
gels or bath foams.
Interstitial cystitis (IC), also known 
as painful bladder syndrome, should not 
be confused with cystitis. IC is a chronic 
bladder inflammation that is not bacterial 
in origin. It affects both sexes and known 
causes are sexual intercourse, mental and/or 
physical stress and menses in women. IC may 
occur in association with other conditions, 
such as sinusitis, hay fever, fibromyalgia, 
migraines and food allergies.4 Treatment 
does not involve antibiotics but requires 
personalized detailed patient education. 
Patients must be well informed on potential 
trigger factors. This will help patients enjoy 
long periods of remission and a better 
quality of life.
Risk factors
Cystitis commonly occurs in females; about 
20% of women, sooner or later, develop a 
UTI.5 This is mainly due to women having a 
shorter urethra than men. Women aged 18-
30 years are very prone to getting cystitis; 
sexually active females are at a greater risk 
of developing cystitis as sexual intercourse 
can result in bacteria being pushed into the 
urethra. Hormonal changes that occur in 
pregnancy and the use of diaphragms also 
attribute to an increased risk of cystitis. 
Altered hormonal levels in postmenopausal 
women and a bladder or uterine prolapse may 
cause incomplete bladder emptying are also 
associated with cystitis.1 Cystitis may also 
arise as a complication of another illness, an 
example being diabetes.
On the other hand, cystitis is quite rare 
in younger men and children. Whenever a 
man presents with symptoms pertaining to 
cystitis he should be immediately referred to 
a doctor as the symptoms may be indicative 
of an underlying pathology, such as stones in 
the bladder or an enlarged prostate.2 
Children are very susceptible to kidney 
and bladder damage as a result of a urinary 
tract infection. A UTI in children may be an 
indication of structural abnormalities within 
the urinary tract and it hence merits further 
investigations by a urologist.
Signs and symptoms
The symptoms of cystitis are very similar 
to the ones an individual experiences when 
suffering from acute urethritis that arises 
due to sexually transmitted diseases.3 The 
symptoms of vaginitis are also very similar 
to those of cystitis, although the former 
is often characterized by the presence of 
vaginal odour, dyspareunia and vaginal 
discharge.5 It is thus of major importance 
that other conditions are ruled out before 
treating an individual for cystitis.
Typical signs and symptoms pertaining to 
cystitis are presented in Table 1.
Catheterised and elderly patients may 
present with atypical symptoms which will 
unfortunately delay a correct diagnosis 
and hence the appropriate treatment to 
be given.6 Such atypical symptoms are 
presented in Table 2.
Diagnosis
Various diagnostic studies confirm cystitis. 
These include a urine dipstick test, urinalysis 
and a bacterial culture. Imaging studies are 
not indicated in the routine evaluation of 
cystitis.5 A dipstick test is usually sufficient 
to diagnose an episode of cystitis. This may 
be performed by a pharmacist or doctor and 
is very cost-effective and convenient to carry 
out. Ideally, a mid-stream urine is used to 
perform the test to remove the commensal 
flora in order to avoid contamination.7
The dipstick test may result in 
microscopic haematuria, proteinuria, 
a positive nitrate test and a positive 
leukocyte esterase test. These are 
all indicative of a UTI. The most 
accurate indicators - 98% - of an acute 
uncomplicated episode of cystitis in 
symptomatic individuals are the presence of 
nitrites and leukocyte esterase in the urine 
sample.7 According to the guidelines issued 
by the local National Antibiotic Committee 
for antibiotic use in LUTIs in the community 
setting, a negative dipstick test excludes a 
UTI, including cystitis. On the other hand, a 
positive test does not necessarily confirm a 
UTI but the presence of leukocyte esterase 
and nitrites may indicate the presence of a 
UTI.8 
The dipstick test makes use of the 
Kastle–Meyer test which detects the 
peroxidase activity of red blood cells.  
In this test, the chemical indicator, 
phenolphthalein is used to detect the 
possible presence of haemoglobin. 
Haemoglobin catalyses the oxidation of the 
colourless reduced form of phenolphthalein 
into phenolphthalein. The latter is visible as 
a bright violet colour. False-positive results 
may result due to a contaminated specimen 
container or due to the presence of semen 
in the urine. Blood in the urine may also 
be due to vaginal bleeding or bleeding 
haemorrhoids.7  The detection of haematuria 
can therefore give rise to a high rate of 
false positives and also false negatives. 
For this reason, this test is unreliable and 
cannot be considered in isolation.7  
Normal urine contains very little protein 
which consists mainly of low-molecular-
weight serum proteins that have been 
filtered by the glomerulus and proteins that 
are produced in the genitourinary tract. 
The albumin content of urine is normally 
low because most of this protein is not 
filtered at the glomerulus. A large amount 
Table 1: Typical signs and symptoms of cystitis
•	 A strong, persistent urge to urinate
•	 Haematuria
•	 Dysuria
•	 Lower back and/or abdominal pain and discomfort
•	 Fever 
•	 Malaise
•	 Pressure in lower pelvis 
Table 2: Atypical signs and symptoms of cystitis
•	 Abdominal pain
•	 Nausea and vomiting
•	 Urinary retention
•	 Altered mental state
•	 Worsening in the control of diabetes
•	 Rigors
•	 New-onset incontinence 
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of any filtered albumin is reabsorbed by 
the tubules. Other proteins found in urine 
may include small amounts of tubular 
microglobulins. The urinary dipstick test only 
detects the presence of albumin. A negative 
protein result therefore does not rule out the 
presence of globulins. This test is therefore 
also unreliable and of little diagnostic value.7 
The urine dipstick test to check for 
proteinuria is based on the fact that certain 
indicators vary in colour in the presence of 
protein even though the pH of the medium 
remains the same. This occurs because 
proteins tend to accept hydrogen ions from 
the indicator on the test strip. The dipstick 
test is very sensitive to albumin because 
albumin contains more amino groups than 
other proteins. For this reason, albumin 
can accept more hydrogen ions. Indicators 
appear yellow in the absence of protein but 
as the protein concentration increases, the 
colour change progresses through various 
shades of green.7
Nitrites are not normally present in the 
urine. They are produced when Gram negative 
bacteria, examples being Eschericia coli, 
Enterobacter and Klebsiella reduce dietary 
nitrates to nitrites. In order for the nitrate 
test to be reliable, the urine specimen 
should be one that has been present in 
the bladder for at least four hours so that 
sufficient time elapses for the nitrate to 
nitrite conversion to take place. Negative 
results in the presence of clinical symptoms 
can be obtained and this may be due to the 
presence of non nitrate-reducing micro-
organisms. Also, some bacteria can convert 
nitrite to nitrogen and this too will give a 
false negative result.7
White blood cells contain an enzyme 
called leukocyte esterase. This is released 
when the white blood cells undergo lysis. 
Very few white blood cells are usually 
present in the urine for the dipstick test to 
be positive. However, when there is a large 
number of white blood cells present in the 
urine, as in the case of a UTI, a positive 
result is obtained. The reaction that takes 
place is based on the fact that the leukocyte 
esterase catalyses the hydrolysis of an ester 
of indolecarboxylic acid on the reagent strip. 
As a result, the indoxyl that is liberated 
combines with a diazonium salt. A violet 
coloured azole dye is subsequently obtained.7
Urine microscopy may be necessary 
if the dipstick test is negative and the 
patients are experiencing the clinical 
symptoms that are normally associated with 
cystitis. Some patients - immunosuppressed 
patients, pregnant women, children under 
three years of age, individuals who have 
recurrent UTIs, those who have had a recent 
urinary tract intervention and those who 
are of an advanced age - who experience 
the symptoms of cystitis must be subject 
to a urine culture test at all costs as the 
dipstick test is considered to be unreliable.1,7 
Bacterial culture is not usually necessary 
to confirm the diagnosis of an episode 
of cystitis in a non-pregnant woman. If 
however she does not respond to first-line 
treatment, her urine should be cultured 
so that the appropriate medication will be 
prescribed.7
Microscopy is used to determine 
haematuria, bacteriuria and pyuria. 
Haematuria is not always present in cystitis 
and it can also be associated with other 
conditions, an example being neoplasia. 
Bacteriuria, especially with pyuria, highly 
suggests an infection whereas pyuria 
occurring in isolation is an indicator of a 
urinary tract inflammation; it however does 
not confirm the presence of an infection.7  
Treatment
Pharmacotherapy in cystitis aims to:
•	 provide symptomatic relief to the 
patients 
•	 eradicate the infection  
•	 prevent complications - early treatment 
is recommended to reduce the risk of 
complications.  
The diagnosis and management of 
uncomplicated acute episodes of cystitis 
are relatively straightforward to handle. On 
the other hand, recurrent and complicated 
infections require more specialized 
assessment. Without any treatment, 25-
42% of uncomplicated episodes of cystitis 
in women will resolve spontaneously. 
The chance of these women developing 
pyelonephritis is around 2%.5
The treatment for cystitis varies as it 
depends on the underlying cause. Cystitis 
that occurs because of radiation therapy 
involves adequate hydration to flush out 
any irritants and also pain management. 
For chemical cystitis it is recommended 
to discontinue the use of the irritating 
products. 
At times, it is impossible for some 
patients to visit their doctors. Studies have 
demonstrated that there may be incidences 
when women who self-diagnose a UTI are 
treated safely via telephone management.5 
Women who have previously suffered from 
acute uncomplicated cystitis are usu-
ally correct in determining when they are 
suffering from another episode.
Paracetamol and Non-steroidal anti-
inflammatory drugs (NSAIDs) 
These medications act as antipyretics 
and also reduce the pain or discomfort 
experienced by the patient. NSAIDs 
reduce the production of prostaglandins 
by inhibiting cyclo-oxygenase. They vary 
in their selectivity for inhibiting the 
different types of cyclo-oxygenase; the 
NSAIDs that are selective cyclo-oxygenase-2 
inhibitors, such examples being etoricoxib 
and celecoxib, are associated with less 
gastrointestinal intolerance. They hence 
reduce the risk of peptic ulceration. In 
the elderly and other high risk patients, 
the use of a proton pump inhibitor (PPI) 
is highly recommended together with 
the cyclo-oxygenase-2 inhibitor. It is of 
utmost importance that on dispensing, the 
pharmacist informs the patient to take the 
NSAIDs after food in order to further reduce 
gastrointestinal upset. On the other hand, 
the PPI is ideally taken one hour before 
breakfast.
Alkalinising agents
Alkalinising agents include sodium 
bicarbonate, sodium citrate, potassium 
citrate and sodium carbonate. Although 
there is no clinical evidence to support their 
use, sources claim that they actually relieve 
discomfort.2      
The recommended dosage for the 
preparations that are available locally is 
one sachet three times a day for two days. 
If the symptoms do not subside, patients 
ought to be referred to a doctor as further 
investigations and/or antibiotic therapy may 
be required. 
Since the sodium content in the sachets 
is relatively high, these preparations should 
be avoided in individuals who are on a diet 
that requires a restricted salt intake. They 
should also be avoided in hypertensive 
patients as they will cause fluid retention 
and further increase the blood pressure. 
Diabetics, pregnant women, patients who 
have heart disease and/or renal failure 
should also avoid these products as these 
patients, as previously noted, should 
be referred immediately.2 It is of major 
importance that patients who are on lithium 
therapy should not be given these sachets 
because sodium is preferentially absorbed 
by the kidney. Lithium excretion is hence 
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increased thus resulting in reduced plasma 
concentrations.9 
These sachets must also be used with 
caution in patients who are on medications 
that require an acidic urine to be excreted.10 
Patients taking certain medications that 
increase the potassium level, such as 
potassium sparing diuretics, aldosterone 
antagonists and angiotensin converting 
enzyme inhibitors, should consult the 
doctor before taking the potassium-salt 
containing sachets because of the risk of 
hyperkalaemia.2 
D-Mannose
According to The National Institute for 
Health and Care Excellence Guidelines, 
D-Mannose is the most effective over-
the-counter supplement for preventing and 
treating urinary tract infections. Similar 
to glucose in structure, D-mannose is a 
naturally occurring sugar and can be found 
in several fruits such as apples, blueberries, 
and cranberries.  D-mannose is effective 
because it attaches itself to Escherichia coli 
and as a result, the bacteria are eliminated 
from the body during micturition. Even if 
taken in large quantities, D-mannose does 
not cause any adverse effects. It is safe in 
diabetics and can be easily taken by patients 
who have to avoid sugar.11 The preparation 
that is available locally should be taken 
twice daily for a week and ideally should be 
continued even after the infection subsides 
so as to ensure complete elimination of the 
bacteria in the urinary tract. Individuals who 
are prone to recurrent urinary tract infections 
can take D-mannose on a regular basis as a 
means of prevention. 
Antibiotics
According to the 2010 Infectious Diseases 
Society of America (IDSA) guidelines, no 
antibiotic is considered as being ideal for 
treating acute uncomplicated episodes of 
cystitis.  The choice of antibiotic depends 
on several factors and these include the 
medication’s efficacy, any associated adverse 
side effects and the resistance the micro-
organisms exhibit.5 The prevalence of 
antibiotic-resistant infections tends to 
be higher in patients who suffer from 
recurrent infections and who have taken 
various antibiotics due to other illnesses. 
Physicians should also consider ease of 
availability, cost and individual patient 
factors, such as a history of allergy. 
Although published guidelines offer 
choices for the various antibiotics that 
can be prescribed by doctors, studies have 
shown that prescribing practices vary 
tremendously.
Since most cases of cystitis are 
caused by Escherichia coli, it is of 
major importance that this microbe is 
not resistant to the antibiotic that is 
chosen for empirical treatment. The 
resistance patterns of Escherichia coli vary 
considerably between countries. A specific 
recommended treatment protocol may 
therefore not be suitable for all regions.12  
According to the IDSA guidelines, 
the antibiotics that are to be considered 
as the treatment of choice for 
uncomplicated and acute episodes of 
cystitis in women include nitrofurantoin 
or trimethoprim-sulfamethoxazole or 
fosomycin. Fluoroquinolones are usually 
used to treat complicated episodes of 
cystitis and should not be used as a 
first line for the empirical treatment of 
LUTIs. Their use should be guided by 
culture and sensitivity results. Beta-
lactam antibiotics may be prescribed 
when other recommended medications 
cannot be used. For instance, fosfomycin 
and nitrofurantoin should be avoided in 
patients who suffer from a possible early 
episode of pyelonephritis.5  
The Maltese National Antibiotic 
Committee issued treatment guidelines for 
the treatment of UTIs in the community.8 
These are presented in Table 3.
The local guidelines stipulate that in 
women and children, a three day course of 
antibiotics is usually sufficient to cure an 
uncomplicated acute case of cystitis whereas 
males and pregnant women should be 
treated for at least 7 days. Children suffering 
from upper UTIs should also be treated for 7 
to 10 days.8  
It is clearly shown that the local 
guidelines differ from the 2010 IDSA 
guidelines. Co-trimoxazole, for example 
is presently no longer indicated for the 
empirical treatment of LUTIs. This contrasts 
with the local widespread use of this drug 
over twenty years ago. 
Pharmacists are in a key position 
in advising the patient on the proper 
administration of the medication. It is to be 
noted that on average, patients will begin 
experiencing symptom relief within 36 hours 
of commencing the treatment. The whole 
course of antibiotics must be taken even if 
the patient feels better before completion. 
Nitrofurantoin monohydrate
Nitrofurantoin is highly effective against 
Escherichia coli, many Gram negative 
bacteria and Gram positive cocci. The 
duration of therapy for nitrofurantoin has 
been reduced to five days in the 2010 IDSA 
guidelines. This varies from the stipulated 
seven day treatment recommended in the 
previous 1999 guidelines.5 Nitrofurantoin 
is generally well tolerated, with no 
significant effects on vaginal flora. It is 
contraindicated in patient with impaired 
renal function and possible adverse effects 
include nausea, vomiting, hypersensitivity, 
peripheral neuropathy, hepatitis and 
haemolytic anaemia.9 Nitrofurantoin lacks 
significant drug interactions although 
administration with alkalising agents renders 
the antimicrobial ineffective due to the 
alkaline pH. The pharmacist should advise 
the patient to take the medication with 
food and not to get alarmed if the urine is 
coloured yellow or brown. Nitrofurantoin 
is unlikely to cause problems to the foetus 
if given for a short period in pregnancy. It 
however cannot be given at term or during 
breastfeeding.
Table 3: Maltese guidelines to treat UTIs in the community
UTI in pregnancy
UTI in children
LUTI in men and women (no fever)
First line: nitrofurantoin 




If pH< 7: nitrofurantoin
If pH>7: coamoxiclav
50-100mg qds x 7 days
500mg tds x 7 days
500mg tds x 7 days
15mg/kg/dose tds x 3 days 
10-15mg/kg/dose bd x 3 days
50-100mg qds; female x 3 days and males x 7 days  
625mg tds; female x 3 days and males x 7 days
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Trimethoprim–sulfamethoxazole 
These two antibiotics are used in 
combination due to their synergistic 
activity.  They interfere with two consecutive 
steps in the biosynthesis of nucleic acids 
and proteins that are essential to many 
bacteria.5 Trimethoprim inhibits dihydrofolate 
reductase; the synthesis of tetrahydrofolic 
acid from dihydrofolic acid is therefore 
inhibited. Sulfamethoxazole, on the other 
hand, inhibits the synthesis of dihydrofolic 
acid by competing with para-aminobenzoic 
acid. Co-trimoxazole should not be prescribed 
to individuals who have already taken it in 
the previous three months for cystitis. This 
antibiotic has been associated with rare, 
but serious adverse effects which include 
Stevens-Johnson syndrome, photosensitivity 
reactions and blood dyscrasias. More common 
adverse effects include diarrhoea, nausea and 
headache.9 The pharmacist ought to advise 
the patient regarding adequate fluid intake 
whilst taking the antibiotic and to also avoid 
direct sunlight. Patients taking warfarin 
should not be prescribed co-trimoxazole 
because of the increased anticoagulant 
effect due to trimethoprim.9 There is also 
an increased risk of hyperkalaemia when 
trimethoprim is given with angiotensin 
converting enzyme inhibitors or angiotensin 
II receptor antagonists.9
Fosfomycin tromethamine 
In the United States fosfomycin is not 
widely available because it is considered to 
be less effective than standard short-course 
regimens. This antibiotic inhibits bacterial 
cell wall synthesis and also reduces bacterial 
adherence to the urinary tract.  Adverse 
effects may include diarrhoea, nausea, 
vomiting, drowsiness and pruritus.5 The 
pharmacist should advise the patient to add 
the sachet contents to a glass of cold water, 
to stir it and drink it straight away, ideally in 
the evening, with or without food. Symptoms 
should improve within two to three days after 
taking the medication; if symptoms persist 
or worsen, the doctor must be contacted. 
It is very important to inform the patient 
not to use more than one sachet as more 
packets will not make the medication work 
better. On the other hand, adverse effects 
will be increased. It would be very useful to 
limit the local use of this new medication 
because fosfomycin is active against most 
local multidrug resistant strains of Gram 
negative organisms. It will therefore save on 
the use of second line antibiotics, such as 
carbapenems within the hospital setting.  
Quinolones
Quinolones are very effective against Gram 
negative bacteria and to a lesser extent also 
inhibit Gram positive bacteria. Unfortunately, 
resistance to quinolones is on the increase.5 
The use of low dose ciprofloxacin is replacing 
older quinolones (norfloxacin) due to the 
former’s better pharmacokinetic properties. 
Quinolones should be used with caution 
in patients who have a history of epilepsy 
since a main adverse effect is that they may 
induce convulsions. Other adverse effects 
may include rash, headache, restlessness, 
an Achilles tendon rupture especially in 
patients who are older than 60 years and 
a QT interval prolongation. The community 
pharmacist should advise the patient to 
take the medications after food and to 
avoid direct sunlight due to photosensitivity 
reactions. Dairy products should not be 
taken with quinolones as the absorption 
of the medication will be reduced. Very 
important interactions involving quinolones 
include those with warfarin – where the 
anticoagulant effect is enhanced – and 
NSAIDs – where the risk of convulsions is 
increased if they are given concomitantly.9 
Also, ciprofloxacin should not be given with 
calcium supplements and alkalising agents 
due to the risk of chelation and crystalluria 
respectively. 
Beta-lactam antibiotics 
Cephalosporins are rarely indicated for 
LUTIs because of increased resistance 
by Gram negative bacteria. Amoxicillin 
should be avoided as much as possible 
because resistance to this agent is also 
very high.  Beta-lactam antibiotics tend to 
have inferior efficacy and more associated 
adverse effects than nitrofurantoin.5 They 
therefore should be used with extreme 
caution in uncomplicated cases of cystitis. 
The pharmacist should advise the patient 
regarding possible adverse effects which 
can be avoided; the individual should take 
probiotics with the antibiotic so as to 
prevent diarrhoea and use an intimate wash 
to help avoid vaginal candidiasis.  
Women who suffer from more than 
three recurrent UTIs a year should take 
prophylactic antibiotics in addition to 
behavioural modification. Women whose 
recurrent UTIs are associated with sexual 
intercourse should take a single dose 
of an effective antibiotic as post-coital 
prophylaxis.5 Local guidelines recommend a 
50mg nitrofurantoin STAT dose.  Prophylactic 
antibiotic use should not be taken for 
more than six to twelve months due to the 
risk of bacterial resistance and also due 
to the occurrence of adverse effects, such 
as gastrointestinal effects and rashes.10,13 
Patients should be well informed about 
the fact that the antibiotic prophylaxis 
is not usually a life-long treatment. The 
medication, however, is to be taken for 
the required period of time so as to allow 
adequate healing of the bladder to take 
place and it should ideally be taken at night 
when urine flow is rather low.10 Men and 
patients who have an indwelling catheter 
should not take a daily dose of prophylactic 
antibiotic therapy unless the medications are 
prescribed by a urologist, microbiologist or 
nephrologist.14 
Probiotics
Probiotics can be defined as, “live 
microorganisms, which when administered in 
adequate amounts confer a health benefit on 
the host”.15 The micro-organisms that inhabit 
the vaginal tract play a very important 
role in the prevention of infections and 
also in the maintenance of good health. 
About 50 different types of microbial 
species inhabit the vagina. The species 
that are present in the vaginal mucosa vary 
between premenopausal and postmenopausal 
women. The microbial flora of a healthy 
premenopausal woman is normally dominated 
by the Lactobacillus species. Various factors 
such as hormonal changes (especially in 
oestrogen levels) and vaginal pH can affect 
the colonization of the Lactobacilli in the 
vagina. Spermicides for example, lead to 
a loss of Lactobacilli and alter the pH.15 
The growth of Gram-negative organisms 
is therefore stimulated, thus resulting in 
cystitis.
Lactobacilli are required in the vaginal 
mucosa for various reasons - they produce 
antibacterial materials, an example being 
hydrogen peroxide, so as to limit pathogen 
growth. They also produce biosurfactants 
that inhibit pathogen adherence to the 
mucosa and attract macrophages, leucocytes 
and other host defences to the particular 
area.15
Clinical trials have demonstrated that 
a number of strains of Lactobacilli are very 
effective at helping to treat and prevent 
cystitis.  Taking Lactobacillus probiotics daily 
as prevention for cystitis offers advantages 
over long term preventive antibiotic therapy; 
probiotics do not cause antibiotic resistance 
and unlike antibiotics allow re-colonization 
of bacteria to take place.15
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Cranberry oral preparations
The mechanism of action of cranberries as 
a prevention of cystitis has not been fully 
understood. Cranberries contain water (as 
their main constituent) and carbohydrates.  
Benzoic acid in cranberry juice is excreted 
in urine as hippuric acid which is a 
bacteriostatic agent; it has the potential 
to acidify urine. Studies have also shown 
that in petri dishes, cranberry metabolites 
prevent Escherichia coli from adhering to 
other bacteria, hence limiting its ability 
to grow and multiply.10,16 Despite this, 
results of studies are rather inconsistent 
and the required dose to be taken is 
unclear.10 Women should be advised that 
high strength cranberry capsules are more 
effective than cranberry juice. Flavonoids, 
which are constituents of cranberries, 
have an effect on the cytochrome P450 
drug-metabolizing enzyme. Flavonoids 
together with the salicylate content of 
the juice enhance the anticoagulant effect 
of coumarins, so concomittant use with 
warfarin should be avoided.16 Cranberry 
juice has also been reported to delay the 
absorption of Beta-lactam antibiotics.
It is important to point out that both 
IDSA and Maltese National guidelines do 
not mention the use of probiotics and 
cranberry tablets.
Lifestyle recommendations
Lifestyle changes that will surely help 
reduce the severity and incidence of 
cystitis include:
•	 avoiding perfumed soaps, tight 
clothing and other potential irritants, 
such as deodorant sprays 
•	 maintaining good toilet hygiene 
-  wiping from front to back after 
a bowel movement helps prevent 
bacteria in the anal region from 
spreading to the vagina and urethra 
•	 drinking large quantities of water 
(about 2L a day) so as to flush out 
the bladder and reduce the acidity of 
the urine by dilution
•	 avoiding foods and drinks that 
contribute to cystitis, examples being  
alcohol, spices, chocolate, caffeine, 
citrus beverages, tomatoes, vitamin C 
and citrus fruits
•	 urinating frequently without delay
•	 not using a spermicide but considering 
alternative methods of contraception
•	 taking showers rather than baths 
•	 using tampons for periods
•	 wearing cotton underwear
•	 using an oestrogen cream in some 
postmenopausal women 
Conclusion
Men, children under 16 years of age, 
pregnant women and individuals suffering 
from certain conditions that include 
diabetes, heart and/or renal disease should 
be immediately referred to a physician 
if they suffer from symptoms pertaining 
to cystitis. A specific recommended 
treatment protocol is not suitable for all 
countries because the resistance patterns of 
Escherichia coli vary considerably.
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Key points
•	 Episodes of cystitis are quite common in females but they are relatively rare in men 
and children
•	 A woman is said to have recurrent UTIs if she suffers from three episodes in the 
past twelve months or two in the previous six months
•	 Prophylactic antibiotic therapy should be taken at night when the urine flow is 
low; ideally, it should not be taken for more than six to twelve months
•	 When possible, urine specimens should be collected before initiating antibiotic 
therapy so as to avoid interference with laboratory findings
